Memantine Hydrochloride
- Product NDC
- 71034-008
- 11-digit product format
- 710340008
- Labeler code
- 71034
- Product ID
- 71034-008_ead45c12-3bc3-6c52-e053-2995a90ad798
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- memantine hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Xiamen LP Pharmaceutical Co., Ltd.
- Application
- ANDA213985
- Marketing category
- ANDA
- Marketing start
- 2022-10-21
- Marketing end
- 0000-00-00
- Substance
- MEMANTINE HYDROCHLORIDE
- Active strength
- 14 mg/1
- Pharmacologic classes
- N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71034-008-30 | 71034000830 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71034-008-30) | 2022-10-21 | 0000-00-00 | No | No | Current |